# SAXAGLIPTIN
> **ANDA205959** · Abbreviated New Drug Application (Generic) · Sponsor: PAR PHARM · Approved 2016-08-17
## Drug
- **FDA Application Number:** ANDA205959
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SAXAGLIPTIN
- **Generic name:** Saxagliptin
- **Active ingredients:** SAXAGLIPTIN
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** PAR PHARM
- **First approval:** 2016-08-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205959)
---
*AI Analytics · CC0 1.0*